Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

AbstractObjective:Seventy percent of postmenopausal women experience vasomotor symptoms, which can be highly disruptive and persist for years. Hormone therapy and other treatments have variable efficacy and/or side effects. Neurokinin B signaling increases in response to estrogen deficiency and has